Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease
…, V Alvarez, F Zou, O Valladares, SG Younkin, E Coto… - Nature …, 2013 - nature.com
Eleven susceptibility loci for late-onset Alzheimer's disease (LOAD) were identified by previous
studies; however, a large portion of the genetic risk for this disease remains unexplained. …
studies; however, a large portion of the genetic risk for this disease remains unexplained. …
Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease
…, A Frank-Garcia, E Porcellini, O Hanon, E Coto… - Nature …, 2011 - nature.com
We sought to identify new susceptibility loci for Alzheimer's disease through a staged
association study (GERAD+) and by testing suggestive loci reported by the Alzheimer's Disease …
association study (GERAD+) and by testing suggestive loci reported by the Alzheimer's Disease …
Unified criteria for ultrasonographic diagnosis of ADPKD
…, E Dicks, P Parfrey, B Cramer, E Coto… - Journal of the …, 2009 - journals.lww.com
Individuals who are at risk for autosomal dominant polycystic kidney disease are often screened
by ultrasound using diagnostic criteria derived from individuals with mutations in PKD1. …
by ultrasound using diagnostic criteria derived from individuals with mutations in PKD1. …
APOE and Alzheimer disease: a major gene with semi-dominant inheritance
…, N Fiévet, N Brouwers, K Bettens, B Arosio, E Coto… - Molecular …, 2011 - nature.com
Apolipoprotein E (APOE) dependent lifetime risks (LTRs) for Alzheimer Disease (AD) are
currently not accurately known and odds ratios alone are insufficient to assess these risks. We …
currently not accurately known and odds ratios alone are insufficient to assess these risks. We …
Comparison of phenotypes of polycystic kidney disease types 1 and 2
N Hateboer, MA v Dijk, N Bogdanova, E Coto… - The Lancet, 1999 - thelancet.com
… N Bogdanova did the genetic analysis of the Bulgarian families, Eliecer Coto and S Sanz
de Castro did the genetic and clinical analysis of the families in northern Spain, and S Jeffery …
de Castro did the genetic and clinical analysis of the families in northern Spain, and S Jeffery …
Espectro mutacional de los genes sarcomericos MYH7, MYBPC3, TNNT2, TNNI3 y TPM1 en pacientes con miocardiopatia hipertrofica
M García-Castro, E Coto, JR Reguero… - Revista española de …, 2009 - Elsevier
Introducción y objetivos Las mutaciones en los genes sarcoméricos son la causa más frecuente
de miocardiopatía hipertrófica. Para cada gen, la frecuencia de mutaciones varía entre …
de miocardiopatía hipertrófica. Para cada gen, la frecuencia de mutaciones varía entre …
Genetic variation in the renin-angiotensin system and athletic performance
…, C Rodríguez, S Braga, V Alvarez, E Coto - European journal of …, 2000 - Springer
The D allele at the angiotensin-I-converting enzyme (ACE)-insertion/deletion polymorphism
has been associated with an increased risk of developing several pathological processes, …
has been associated with an increased risk of developing several pathological processes, …
Angiotensin-converting enzymes (ACE, ACE2) gene variants and COVID-19 outcome
…, E Cuesta-Llavona, V Alvarez, R Lorca, E Coto - Gene, 2020 - Elsevier
The Angiotensin system is implicated in the pathogenesis of COVID-19. First, ACE2 is the
cellular receptor for SARS-CoV-2, and expression of the ACE2 gene could regulate the …
cellular receptor for SARS-CoV-2, and expression of the ACE2 gene could regulate the …
[HTML][HTML] Mutations in filamin C cause a new form of familial hypertrophic cardiomyopathy
…, A Gutiérrez-Fernández, J Gómez, E Coto… - Nature …, 2014 - nature.com
Mutations in different genes encoding sarcomeric proteins are responsible for 50–60% of
familial cases of hypertrophic cardiomyopathy (HCM); however, the genetic alterations causing …
familial cases of hypertrophic cardiomyopathy (HCM); however, the genetic alterations causing …
Gut microbiota dysbiosis in a cohort of patients with psoriasis
Background There is increasing evidence of the key role that the gut microbiota plays in
inflammatory diseases. Objectives To identify differences in the faecal microbial composition of …
inflammatory diseases. Objectives To identify differences in the faecal microbial composition of …